Ascension Authors Publish Covid Study in BMJ Quality & Safety

Congratulations to our very own Ascension Clinical Network Services Leaders:

Dr. Mohamad Fakih,

Dr. BalighYehia, 

Dr. Richard Fogel, 

and Dr. Joseph Cacchionone,

working with other Ascension data science professionals, 

for publishing a timely and relevant article relative to the ongoing pandemic

in BMJ Quality & Safety.

Thank you for sharing you expertise, knowledge, and commitment to with the wider world.

COVID-19 hospital prevalence as a risk factor for mortality: an observational study of a multistate cohort of 62 hospitals

Mohamad Ghazi Fakih 1, Allison Ottenbacher 2, Baligh Yehia 3, Richard Fogel 3, Collin Miller 2, Angela Winegar 2, Christine Jesser 4, Joseph Cacchione 3

BMJ Quality & Safety

2021 Oct 5;bmjqs-2021-013721.

 doi: 10.1136/bmjqs-2021-013721. Online ahead of print.

PMID: 34611041

 

PMCID: PMC8494532

 

DOI: 10.1136/bmjqs-2021-013721 

Link to Article

Abstract:

Background: The associated mortality with COVID-19 has improved compared with the early pandemic period. The effect of hospital COVID-19 patient prevalence on COVID-19 mortality has not been well studied.

Methods: We analysed data for adults with confirmed SARS-CoV-2 infection admitted to 62 hospitals within a multistate health system over 12 months. Mortality was evaluated based on patient demographic and clinical risk factors, COVID-19 hospital prevalence and calendar time period of the admission, using a generalised linear mixed model with site of care as the random effect.

Results: 38 104 patients with COVID-19 were hospitalised, and during their encounters, the prevalence of COVID-19 averaged 16% of the total hospitalised population. Between March-April 2020 and January-February 2021, COVID-19 mortality declined from 19% to 12% (p<0.001). In the adjusted multivariable analysis, mid and high COVID-19 inpatient prevalence were associated with a 25% and 41% increase in the odds (absolute contribution to probability of death of 2%-3%) of COVID-19 mortality compared with patients with COVID-19 in facilities with low prevalence (<10%), respectively (high prevalence >25%: adjusted OR (AOR) 1.41, 95% CI 1.23 to 1.61; mid-prevalence (10%-25%): AOR 1.25, 95% CI 1.13 to 1.38). Mid and high COVID-19 prevalence accounted for 76% of patient encounters.

Conclusions: Although inpatient mortality for patients with COVID-19 has sharply declined compared with earlier in the pandemic, higher COVID-19 hospital prevalence remained a common risk factor for COVID-19 mortality. Hospital leaders need to reconsider how we provide support to care for patients in times of increased volume and complexity, such as those experienced during COVID-19 surges.

Keywords: COVID-19; hospital medicine; mortality (standardised mortality ratios).